Related Experiment Video
Updated: Feb 22, 2026

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
Published on: January 17, 2025
Dilated Cardiomyopathy and Later Onset Limb-Girdle Muscular Dystrophy Associated With Fukutin and LaminA/C Mutations
Alejandra Cardona Perez1, Renee Moenning2, Cynthia Bodkin3
1Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Insights
Dilated cardiomyopathy (DCM) can stem from genetic mutations affecting heart and muscle. Early genetic testing is crucial for diagnosing limb-girdle muscular dystrophy (LGMD) and guiding patient care.
Area of Science:
- Cardiology
- Genetics
- Neuromuscular Disorders
Background:
- Nonischemic dilated cardiomyopathy (DCM) can arise from genetic variants impacting myocardial structure and function.
- Mutations in FKTN and LMNA genes can affect both cardiac and skeletal muscles, leading to limb-girdle muscular dystrophy (LGMD).
- Cardiac disease may manifest before neuromuscular symptoms in LGMD patients.
Background:
Nonischemic dilated cardiomyopathy (DCM) can result from pathogenic variants in genes affecting myocardial structure and function. FKTN and LMNA mutations may involve both cardiac and skeletal muscle, consistent with limb-girdle muscular dystrophy (LGMD), with cardiac disease sometimes preceding neuromuscular symptoms.
Case Summary:
We report on 2 adults presenting with advanced DCM requiring heart transplantation, who were later diagnosed with LGMD. A 22-year-old woman had biallelic FKTN variants, and a 37-year-old man carried a heterozygous LMNA pathogenic variant. Both had elevated creatine kinase prior to proximal muscle weakness. Muscle biopsy and genetic testing confirmed dystrophic processes.
Discussion:
These cases demonstrate that genetically mediated DCM may initially present as isolated cardiac disease. Early genetic testing can guide transplant planning, long-term care, and family counseling.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Lysosomal Hydrolases

